Mumbai, Jan. 28 -- Biocon Biologics, subsidiary of Biocontoday announced that S&P Global Ratings has upgraded the Company's long-term issuer credit rating to 'BB+' from 'BB', and revised the outlook to "Stable". The rating on the senior secured notes issued by Biocon Biologics Global PLC has also been upgraded to 'BB+'.
Published by HT Digital Content Services with permission from Capital Market....